- Home
- Companies
- azerbaijan
- pharmaceutical development
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Manufacturing, Other
- Environmental
- Health and Safety
- Water and Wastewater
- Air and Climate
- Food and Beverage
- Energy
- Soil and Groundwater
- Aerospace & Air Transport
- Glassware
- Waste and Recycling
- Agriculture
- University / Academia / Research
- Banking & Finance / Insurance / Legal
- Defense
- Retail
- Paint
- Plastics & Resins
- Oil, Gas & Refineries
- Government
- Construction & Construction Materials
Pharmaceutical Development Suppliers Serving Azerbaijan
138 companies found
based inSan Clemente, CALIFORNIA (USA)
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. At Glaukos, our focus is to develop and lead the ...
based inKraainem, BELGIUM
With over 17,000 staff in around 200 laboratories across 36 countries, Eurofins Scientific is the world leader in food and biopharma product testing. It is also number one in the world in the field of environmental laboratory services and one of the ...
Complete preclinical service: Early and full drug development is regulatory-driven and complex. The priority in this selection process is to achieve the safety and efficacy of a new molecular entity. The preclinical activity ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Joint venture collaboration. Early development stage completed. IP application filed. Advisers retained to explore commercial ...
based inStockholm, SWEDEN
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...
based inMonheim, GERMANY
Cube Biotech was founded by a team of membrane protein experts. Unleashing the power of proteins for research and progress, Cube Biotech supports the pharmaceutical and biotechnical community with all its scientific expertise. By leveraging the ...
based inPrinceton, NEW JERSEY (USA)
Taiho Oncology, Inc. specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a ...
based inSolna, SWEDEN
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® ...
Many intravenously delivered Active Pharmaceutical Ingredients (APIs) are insoluble or poorly soluble in water. This can be a major hurdle in pharmaceutical development and may cause promising drugs ...
based inNanjing, CHINA
CHINNOFI Pharmaceutical Machinery Co., Ltd. is one of the lagest proffesional of sterilization equipment in China. Provide professional solutions for sterilization in various fields. The diversification of the sterilization process is to meet the ...
based inLeiden, NETHERLANDS
We are a global leader in human 3D disease modeling using our organ-on-a-chip platform, the OrganoPlate. We work with top pharmaceutical and biotech companies to develop novel therapies against unsolved diseases. Our human tissue & disease modeling ...
Capture and understand human disease biology in vitro. The key to unlocking effective therapies for the unsolved diseases of our times is a deep understanding of human disease biology. To this end, MIMETAS aims to capture the essence of diseases in ...
based inSomerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceutical Solutions specializes in comprehensive drug development services, providing tailored formulation and manufacturing solutions from pre-formulation stages to commercialization. With a focus on overcoming pharmaceutical ...
EmulSol is a technology for production of oil-in-water nano-emulsions. Nano-emulsions have droplet sizes in the range of 50 to 500 nanometers, and are stable for the intended shelf-life of the product. Ascendia® produces nano-emulsions using a ...
based inAtlanta, GEORGIA (US) (USA)
Apyron Technologies develops and commercializes high-performance, specialty materials needed to tackle global issues faced in a wide range of industries including the environmental, energy, transportation, food and beverage, medical and ...
based inCoralville, IOWA (USA)
A champion of life sciences research for more than 30 years, IDT develops and manufactures nucleic acid products that support the life sciences industry. Areas of focus include academic and commercial research, agriculture, medical diagnostics, ...
based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential ...
based inMilan, ITALY
Italfarmaco SpA is a private Italian multinational company located in Milan, operating in Italy and abroad in both the pharmaceutical and fine chemical industries through its controlled and/or participated companies. Italfarmaco was establish in ...
The Italian manufacturing plant of Italfarmaco is located in the northern area of Milan. The building, rising on an area of approximately 16,000 m2 with multiple blocks of about 10,000 m2, is totally devoted to the manufacturing of injectable ...
based inSayreville, NEW JERSEY (USA)
HERMLE centrifuges have established themselves as indispensable tools for DNA analysis, drug development in the pharmaceutical industry and even standard blood tests at your GP's surgery. We are also well and truly “at home” in the fields of ...
based inNanjing, CHINA
Nanjing Hjchem company provides a solution for every stage of your research processing. We work together various researchers and scientists from laboratory to pilot plant and production scale. Our experienced systems are designed for different ...
based inCo. Cork,, IRELAND
Expo Process Analytics specializes in developing engineered solutions that enable Process Analytical Technology (PAT) across various industries including pharmaceuticals, food, agriculture, and agri-chemicals. These solutions range from research and ...
The FFSim™ Feed Frame Simulator from Expo Process Analytics is an advanced laboratory-scale simulation tool designed to enhance pharmaceutical process development. It provides a modern alternative to ...
based inStockholm, SWEDEN
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several ...
The drug candidate GS-659, which is sprung from Gesynta Pharma’s drug development platform, is currently in preclinical development phase. Project updates will be announced in due ...
